{"log_id": 9065078872165004330, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 2e-06, "average": 0.999013, "min": 0.994732}, "location": {"width": 738, "top": 239, "height": 56, "left": 283}, "words": "临床研究未证实老年人对该药的反应与年轻人不同,因此,老年患者勿需"}, {"probability": {"variance": 4.1e-05, "average": 0.996952, "min": 0.965603}, "location": {"width": 779, "top": 282, "height": 59, "left": 238}, "words": "因年龄而调整剂量。如患者伴有严重肝肾功能、心功能减退,用药期间应注意"}, {"probability": {"variance": 4e-06, "average": 0.99854, "min": 0.994277}, "location": {"width": 188, "top": 331, "height": 34, "left": 238}, "words": "观察,可酌情减量"}, {"probability": {"variance": 1.1e-05, "average": 0.997305, "min": 0.989066}, "location": {"width": 170, "top": 391, "height": 31, "left": 243}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.000672, "average": 0.99379, "min": 0.852465}, "location": {"width": 734, "top": 435, "height": 55, "left": 277}, "words": "锂剂与血管紧张素Ⅱ受体拮抗剂及血管紧张素转化酶抑制剂合用,可引起"}, {"probability": {"variance": 4.2e-05, "average": 0.996341, "min": 0.971707}, "location": {"width": 760, "top": 479, "height": 54, "left": 232}, "words": "可逆性的血锂水平升高和毒性反应,因此锂剂和本品合用须慎重。如需合用"}, {"probability": {"variance": 0.00015, "average": 0.993131, "min": 0.954613}, "location": {"width": 282, "top": 525, "height": 36, "left": 228}, "words": "则合用期间应监测血锂水平"}, {"probability": {"variance": 0.001309, "average": 0.991888, "min": 0.79122}, "location": {"width": 737, "top": 569, "height": 56, "left": 272}, "words": "与其他抑制血管紧张素I及其作用的药物一样,本品与引起血钾水平升高"}, {"probability": {"variance": 0.000157, "average": 0.995183, "min": 0.927647}, "location": {"width": 778, "top": 612, "height": 56, "left": 226}, "words": "的药物(血管紧张素转化酶抑制剂、保钾利尿药、钾离子补充剂、含钾的盐替"}, {"probability": {"variance": 3.8e-05, "average": 0.995741, "min": 0.972843}, "location": {"width": 779, "top": 656, "height": 56, "left": 224}, "words": "代品、环孢菌素A或其他药物如肝素钠)合用,可致血钾升高,建议监测血钾"}, {"probability": {"variance": 0, "average": 0.999825, "min": 0.999677}, "location": {"width": 49, "top": 703, "height": 29, "left": 223}, "words": "水平"}, {"probability": {"variance": 0.001553, "average": 0.985247, "min": 0.777553}, "location": {"width": 864, "top": 732, "height": 124, "left": 218}, "words": "能降低利尿剂和其他抗高血压药的作用,机制尚不明确。因此,本品的抗高"}, {"probability": {"variance": 0.011184, "average": 0.948351, "min": 0.581822}, "location": {"width": 736, "top": 747, "height": 54, "left": 263}, "words": "非甾体抗炎药物( NSAIDS)包括选择性环氧合酶-2(COx-2抑制剂)可"}, {"probability": {"variance": 0.001736, "average": 0.976476, "min": 0.855765}, "location": {"width": 494, "top": 837, "height": 44, "left": 218}, "words": "压作用可能会被 NSAIDS包括COX-2抑制剂削弱"}, {"probability": {"variance": 1.1e-05, "average": 0.997782, "min": 0.986735}, "location": {"width": 734, "top": 882, "height": 54, "left": 260}, "words": "麻黄含有麻黄碱和伪麻黄碱,可降低抗高血压药的疗效,使用本品治疗的"}, {"probability": {"variance": 9e-05, "average": 0.994092, "min": 0.961987}, "location": {"width": 370, "top": 927, "height": 40, "left": 216}, "words": "高血压患者应避免使用含麻黄的制剂"}, {"probability": {"variance": 0.00021, "average": 0.994727, "min": 0.921368}, "location": {"width": 734, "top": 971, "height": 55, "left": 257}, "words": "依据本品的药代动力学特征以及同类药物氯沙坦钾的临床研究结果,推测"}, {"probability": {"variance": 0.007712, "average": 0.966763, "min": 0.564466}, "location": {"width": 783, "top": 1014, "height": 64, "left": 210}, "words": "本品与氟康唑、西咪替丁、利福平、苯巴比妥、氢氯噻嗪、地高法林等"}, {"probability": {"variance": 0.008123, "average": 0.972453, "min": 0.601084}, "location": {"width": 754, "top": 1058, "height": 67, "left": 210}, "words": "不具有临床意义的相互作用,但缺乏相应的研究数据。深生立药业"}, {"probability": {"variance": 2e-05, "average": 0.995995, "min": 0.986148}, "location": {"width": 122, "top": 1124, "height": 29, "left": 215}, "words": "【药物过量】"}, {"probability": {"variance": 0.037892, "average": 0.702058, "min": 0.463471}, "location": {"width": 228, "top": 1118, "height": 43, "left": 770}, "words": "股特限公司心"}, {"probability": {"variance": 8e-05, "average": 0.994909, "min": 0.952555}, "location": {"width": 732, "top": 1168, "height": 50, "left": 250}, "words": "尚无过量使用的病例报告。健康受试者单剂口服本品最高达400mg耐受"}, {"probability": {"variance": 0.018477, "average": 0.952727, "min": 0.426877}, "location": {"width": 776, "top": 1210, "height": 54, "left": 204}, "words": "性良好。用药过量最可能的表现将是低血压和心动过速的于副交感神经(迷"}, {"probability": {"variance": 0.002231, "average": 0.979026, "min": 0.787482}, "location": {"width": 775, "top": 1254, "height": 54, "left": 204}, "words": "走神经)的兴奋,可发生心动过缓。如果发生症状性低血压,该给支持疗"}, {"probability": {"variance": 0, "average": 0.998013, "min": 0.998013}, "location": {"width": 29, "top": 1306, "height": 26, "left": 202}, "words": "法"}, {"probability": {"variance": 0, "average": 0.78676, "min": 0.78676}, "location": {"width": 27, "top": 1321, "height": 27, "left": 771}, "words": "容"}, {"probability": {"variance": 5e-06, "average": 0.998561, "min": 0.989579}, "location": {"width": 453, "top": 1349, "height": 39, "left": 245}, "words": "本品的活性代谢产物不能通过血液透析而清除"}, {"probability": {"variance": 8e-05, "average": 0.993067, "min": 0.974851}, "location": {"width": 120, "top": 1410, "height": 28, "left": 208}, "words": "【临床试验】"}, {"probability": {"variance": 4.2e-05, "average": 0.997518, "min": 0.962953}, "location": {"width": 731, "top": 1453, "height": 46, "left": 243}, "words": "本品抗高血压的疗效已经在3个对照研究中得到证明。其中共有690名患"}, {"probability": {"variance": 3.1e-05, "average": 0.996646, "min": 0.976605}, "location": {"width": 766, "top": 1498, "height": 45, "left": 196}, "words": "者服用本品,138名患者服用安慰剂,407名患者服用阳性对照药物氯沙坦钾"}, {"probability": {"variance": 0.00013, "average": 0.973164, "min": 0.961758}, "location": {"width": 18, "top": 1580, "height": 19, "left": 595}, "words": "11"}], "language": 3}